Kratom Lawsuits in 2026: Addiction, Organ Damage, and Wrongful Death Claims — Who Qualifies

Kratom lawsuits in 2026 are product-liability claims alleging that manufacturers and sellers failed to warn consumers about addiction, organ damage, and death tied to kratom products — especially concentrated 7-OH extracts. Victims and their families may qualify when medical records connect a serious injury or a death to a specific product. This guide explains who qualifies, what changed in 2026, and how these cases are actually built.

Key facts

  • A 2026 CDC analysis found 14,449 kratom exposures reported to U.S. poison centers between 2015 and 2025 — an increase of roughly 1,200%, from 258 cases in 2015 to 3,434 in 2025.
  • Research published in JAMA found reports rising from 19 cases in 2010 to 1,242 in 2023, with 13% of all reported kratom exposures resulting in severe medical outcomes.
  • Publicly reported case outcomes include an $11 million Florida wrongful-death default judgment, a $2.5 million Washington jury verdict, and an $8.75 million consumer class fund from Feel Free (as reported by ConsumerShield). Most individual settlements, however, remain confidential.
  • In late August 2026, federal authorities placed three synthetic kratom-related compounds into Schedule I, and in September 2026 California announced that nearly 7,900 prohibited kratom and 7-OH products had been removed from retailers.
  • The FDA states there are no FDA-approved kratom drug products legally on the U.S. market, and it issued warning letters in July 2025 to companies marketing concentrated 7-hydroxymitragynine (7-OH) products.

What Kratom Is — and Why It Ended Up in Court

Kratom is a tropical tree (Mitragyna speciosa) whose leaves contain mitragynine, a psychoactive alkaloid that interacts with opioid receptors in the brain. Sold in powders, capsules, teas, shots, gummies, and drink mixes at smoke shops, gas stations, and online, it is often marketed as a "natural" botanical product.

A far more potent compound, 7-hydroxymitragynine (7-OH), appears in concentrated extracts that can deliver doses dramatically stronger than raw leaf. Lawsuits allege these products were sold without adequate testing, quality controls, or honest warnings — and that consumers had no idea how powerful, or how dangerous, they were.

Product liability is the area of law that holds manufacturers and sellers responsible when a product injures people because of a design defect, a manufacturing defect, or — most commonly in kratom cases — a failure to warn about known risks.

The Injuries Named in Kratom Lawsuits

Federal health officials and medical researchers have documented serious adverse outcomes following kratom exposure, and the same injuries anchor the litigation:

  • Severe addiction and physical dependence, with withdrawal symptoms including cravings, anxiety, agitation, insomnia, restlessness, muscle aches, nausea, and depression.
  • Seizures and loss of consciousness.
  • Cardiac injuries — rapid heart rate, abnormal rhythms, and cardiac arrest. A 2026 case report in the American Journal of Respiratory and Critical Care Medicine described a healthy 35-year-old man who suffered cardiac arrest after recent kratom use, then developed severe metabolic abnormalities and multi-organ failure before dying.
  • Liver and kidney damage, including liver toxicity documented in clinical reports.
  • Respiratory depression, poisoning, and fatal overdose — in the Krave case, a young man died from what the lawsuit called acute mitragynine intoxication after regular use of high-potency extracts.

Not every kratom exposure leads to a lawsuit. The cases that move forward typically involve hospitalization, lasting organ damage, or death — with medical records tying the harm to the product.

2026 Changed the Legal Landscape

Regulatory pressure on kratom intensified sharply. In July 2025, the FDA issued warning letters to companies marketing products containing concentrated 7-OH, then recommended scheduling action under the Controlled Substances Act — clarifying it was targeting concentrated 7-OH products, not natural leaf. In late August 2026, three synthetic kratom-related compounds were placed into Schedule I. In September 2026, California announced nearly 7,900 prohibited kratom and 7-OH products had been pulled from retailers.

Courts are also letting cases proceed. In March 2026, a federal court in Louisiana partly denied a motion to dismiss a kratom wrongful-death case, ruling that failure-to-warn and defective-design claims against an OPMS product could move forward — a signal that judges are taking these allegations seriously, not treating them as fringe claims.

Cases Moving Through the Courts Right Now

Several active cases illustrate what kratom litigation looks like in 2026:

  • Louisiana, March 2026: a federal court allowed a wrongful-death and product-liability case to proceed against makers and distributors in the kratom supply chain, after Harmony Moller died following use of an OPMS kratom product allegedly sold with inadequate warnings.
  • Missouri, March 2026: a Kansas City-area family filed suit in Jackson County Circuit Court after David Thacker allegedly died from mitragynine exposure, alleging manufacturers sold products without adequate warnings — and that one retailer sold "house blend" kratom in unmarked bags with no warning labels at all.
  • Nevada, August 2026: a man filed suit alleging prolonged use of a kratom product caused severe addiction, withdrawal, and cardiac injuries.
  • The Krave case: a mother alleges her son Martin Soria died on May 30, 2025, from acute mitragynine intoxication after regularly consuming Krave extracts marketed as natural botanical supplements, without warnings about addiction, respiratory depression, or fatal overdose.

Plaintiffs are increasingly targeting not just retailers but manufacturers, distributors, and related business entities throughout the supply chain. For background on how drug-injury mass torts develop, see our guide to Suboxone tooth-decay lawsuits and the gabapentin dementia litigation.

What Compensation Looks Like — Honestly

Compensation varies widely by case, and most settlements are confidential — there is no standard payout chart for kratom claims. Publicly reported benchmarks give a sense of the range courts and juries have reached: an $11 million Florida wrongful-death default judgment, a $2.5 million Washington jury verdict, and an $8.75 million consumer class fund established by Feel Free.

Individual injury or death claims typically resolve for far more than consumer class refunds, but outcomes depend on the facts: the severity of the injury, the strength of the medical evidence, whether the defendant is a small retailer or a well-insured manufacturer, and how clearly the product's warnings failed. No attorney can honestly promise a specific figure before reviewing a case.

Families pursuing death claims should also understand the wrongful-death claim process, which governs who may file and what damages are available.

Who May Qualify for a Kratom Lawsuit

You may have a potential claim if:

  • You or a loved one used a kratom product — powder, capsule, extract, shot, gummy, or drink mix.
  • You suffered a serious injury (addiction requiring treatment, seizure, cardiac event, liver or kidney damage, hospitalization) or a loved one died, with medical records or toxicology suggesting kratom contributed.
  • You can identify the product or the seller — receipts, packaging, store records, or witness accounts all help.

Using kratom to manage withdrawal or substance-use symptoms does not automatically prevent a claim. The key questions remain the same: what product was used, how it was marketed, what warnings were given, and what the medical record shows.

How These Cases Are Built

Kratom cases are typically built on two legal theories. Failure to warn argues the company knew — or should have known — about addiction and injury risks but sold the product as safe or natural without adequate warnings. Defective design argues the product itself, particularly high-potency 7-OH concentrates, was unreasonably dangerous.

Attorneys investigate the supply chain: the retailer who sold it, the distributor who supplied it, and the manufacturer who made it. Product testing can reveal undisclosed concentrations of mitragynine or 7-OH. Medical experts connect the injury to the exposure. And marketing materials — "natural," "safe alternative," wellness claims — become evidence of what consumers were led to believe.

For plain-language explainers on injury claims and consumer protection topics, the Problem Solved channel covers these subjects in short, practical videos.

What to Do If Kratom Harmed You or Someone You Love

  1. Get medical care first. Tell the treating physician about the kratom use — it matters for diagnosis and for the record.
  2. Preserve the product and packaging. Do not throw away containers, bags, receipts, or order confirmations.
  3. Document everything. Dates of use, amounts, symptoms, hospital visits, and names of everyone who saw the product.
  4. Do not wait. Statutes of limitations vary by state and claim type, and deadlines can arrive faster than families expect.
  5. Seek a case review. A product-liability attorney can assess whether the evidence supports a claim — most offer free evaluations.

This article provides general information about kratom-related product-liability litigation. It is not legal or medical advice, and it does not create an attorney-client relationship. Laws vary by state; consult a qualified attorney about your situation.

Who Benefits From This — and Who Does Not

Kratom cases that move forward share one trait: a serious injury or a death, tied by medical records to a specific product. Everything else in this guide — the 2026 rulings, the benchmarks, the warnings — only matters once that trait is present.

Who benefits:

  • People and families with hospitalization, lasting organ damage, or a death tied to a specific product: How: Anchor the claim in medical records connecting the harm to the product — especially concentrated 7-OH extracts — since the cases that move forward typically involve hospitalization, lasting organ damage, or death.
  • Families whose wrongful-death case can proceed on failure-to-warn grounds: How: Note that in March 2026 a federal court in Louisiana partly denied a motion to dismiss a kratom wrongful-death case, ruling that failure-to-warn and defective-design claims against an OPMS product could move forward.
  • People who want an honest read on value before deciding: How: Use the publicly reported benchmarks only as a sense of the range — an $11 million Florida wrongful-death default judgment, a $2.5 million Washington jury verdict, and an $8.75 million consumer class fund from Feel Free — while remembering that most individual settlements are confidential and there is no standard payout chart.

Who benefits little or not at all:

  • People with exposure alone and no serious injury: Not every kratom exposure leads to a lawsuit: the cases that move forward involve hospitalization, lasting organ damage, or death.
  • People expecting a promised figure: No attorney can honestly promise a specific figure before reviewing a case — outcomes depend on the severity of the injury, the strength of the medical evidence, the defendant, and how clearly the warnings failed.
  • People expecting a quick, standard resolution: Individual injury or death claims are judged on their own facts, and the litigation is still developing case by case through the courts.

Read more: Suboxone tooth-decay lawsuits in 2026: dental injury claims

Frequently asked questions

Can you sue for kratom addiction?

Potentially, yes. Addiction and physical dependence are central allegations in kratom lawsuits. A viable claim generally requires evidence of the product used, a documented history of use and withdrawal, medical records, and proof that warnings were inadequate.

Is kratom illegal now?

Natural kratom leaf remains unscheduled at the federal level as of 2026, though some states restrict or ban it. Three synthetic kratom-related compounds were placed in Schedule I in late August 2026, and federal regulators have targeted concentrated 7-OH products specifically.

How long do kratom lawsuits take?

Product-liability cases often take one to three years or longer. Many resolve through confidential settlements before trial, which can shorten — or extend — the timeline depending on the defendant's posture.

What if the product had no warning label at all?

Missing or inadequate warnings can strengthen a failure-to-warn claim. In the Missouri case filed in March 2026, plaintiffs alleged a retailer sold "house blend" kratom in unmarked bags with no warning labels whatsoever.

Do I need to know the exact brand to file?

It helps greatly, but it is not always required. Attorneys can investigate the supply chain through retailer records, distributors, and manufacturers — the Louisiana case targeted companies throughout the chain, not just the store that made the sale.

Who qualifies for a kratom lawsuit — and who does not?

People or families with hospitalization, lasting organ damage, or a death tied by medical records to a specific kratom product — especially a concentrated 7-OH extract — qualify most clearly, and courts are letting such cases proceed: in March 2026 a Louisiana federal court allowed failure-to-warn and defective-design claims against an OPMS product to move forward. People with exposure alone and no serious injury do not: the cases that move forward involve hospitalization, lasting organ damage, or death. And no one should expect a promised figure — publicly reported benchmarks include an $11 million Florida default judgment and a $2.5 million Washington verdict, but most settlements are confidential and there is no standard payout chart. To start, gather the medical records tying the harm to the product and get a case review promptly.

Watch on YouTube

Problem Solved on YouTube